Diabetes drug may hold potential as treatment for epilepsy

Apr 09, 2008

Metformine, a widely used diabetic drug, might also be an effective and safe therapy for epilepsy, researchers report. This new approach may be especially helpful for the subset of patients who have recurrent seizures despite therapy with the best available drugs.

The basis for metformine’s effect is similar to a ketogenic diet, which is an attempt to minimize dietary starch and sugar. Epilepsy patients have been using this severe dietary approach for centuries, which led Dr. Avtar Roopra and colleagues to wonder if drugs could tap into metabolic pathways and produce similar results.

The researchers identified a small molecule in neurons that senses how much energy is available on hand. Glucose normally turns on this sensor, but so does Metformine, a drug used to control blood sugar. By administering the proper dose, they could suppress over-active nerve cells by removing their ability to turn sugar into excess energy.

Roopra and colleagues now hope to apply their preliminary results to a mouse model of epilepsy.

Source: American Society for Biochemistry and Molecular Biology

Explore further: Supercomputers link proteins to drug side effects

add to favorites email to friend print save as pdf

Related Stories

Playing tag with sugars in the cornfield

Sep 25, 2014

Sugars are usually known as energy storage units in plants and the insects that feed on them. But, sugars may also be part of a deadly game of tag between plant and insect according to scientists at the Max ...

Microalgae – the factories of the future

Sep 09, 2014

Biology professor Ralf Kaldenhoff is making microalgae fit for industry. The microorganisms could produce a variety of products from carbon dioxide and light.

Building synthetic plants

Jun 20, 2014

A movement is under way that will fast-forward the design of new plant traits. It takes inspiration from engineering and the software industry, and is being underpinned in Cambridge and Norwich by an initiative ...

Recommended for you

Supercomputers link proteins to drug side effects

Oct 20, 2014

New medications created by pharmaceutical companies have helped millions of Americans alleviate pain and suffering from their medical conditions. However, the drug creation process often misses many side ...

No added benefit proven for umeclidinium/vilanterol in COPD

Oct 20, 2014

The drug combination umeclidinium/vilanterol (trade name Anoro) has been approved since May 2014 for adults with chronic obstructive pulmonary disease (COPD). In an early benefit assessment pursuant to the Act on the Reform ...

User comments : 0